The Latest

• July 28, 2020

  By Jet Encila

  Moderna Enters First-Of-A-Kind Final Phase COVID-19 Vaccine Trials

  Moderna stock rallied almost 10 percent and settled at 79.91 at Monday's close.

  

  Moderna stock rallied almost 10 percent and settled at 79.91 at Monday's close.